Everest Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,844	884.47	523.06	490.79	2,640
Short-Term Investments	887.09	718.84	1,827	1,161	-
Cash & Short-Term Investments	2,731	1,603	2,350	1,651	2,640
Cash Growth	70.36%	-31.77%	42.29%	-37.45%	-41.11%
Accounts Receivable	500.02	363.57	49.86	5.21	0.05
Other Receivables	-	24.69	81.96	1,681	19.52
Receivables	500.02	388.26	131.81	1,687	19.57
Inventory	32.22	14.08	18.94	11.64	0.45
Other Current Assets	109.84	9.98	7.16	64.6	27.86
Total Current Assets	3,374	2,016	2,508	3,414	2,688
Property, Plant & Equipment	656.51	650.04	683.99	643.86	262.64
Long-Term Investments	302.1	29.71	48.93	89.24	830.4
Other Intangible Assets	2,091	2,254	2,524	2,378	2,471
Long-Term Deferred Tax Assets	299.52	-	-	-	-
Other Long-Term Assets	112.36	6.6	6.12	86.69	391.44
Total Assets	6,835	4,959	5,773	6,615	6,646
Accounts Payable	595.7	118.69	95.48	107.52	85.66
Accrued Expenses	-	151.36	73.51	182.07	133.79
Current Portion of Long-Term Debt	74.44	470.21	51.28	424.08	-
Current Portion of Leases	19.48	18.78	18.65	20.33	28.25
Other Current Liabilities	-	34.5	89.82	136.03	22.56
Total Current Liabilities	689.61	793.54	328.74	870.03	270.27
Long-Term Debt	792.12	55.85	429.31	30.92	387.71
Long-Term Leases	40.25	30.77	40	59.31	95.85
Long-Term Unearned Revenue	5.74	5.9	6.05	-	-
Other Long-Term Liabilities	3.5	-	-	-	-
Total Liabilities	1,531	886.05	804.1	960.26	753.83
Common Stock	0.24	0.22	0.22	0.21	0.2
Retained Earnings	-10,554	-10,058	-9,016	-8,172	-7,925
Treasury Stock	-	-	-0	-0	-58.71
Comprehensive Income & Other	15,858	14,130	13,985	13,826	13,875
Shareholders' Equity	5,304	4,073	4,969	5,654	5,892
Total Liabilities & Equity	6,835	4,959	5,773	6,615	6,646
Total Debt	926.28	575.61	539.24	534.64	511.81
Net Cash (Debt)	1,805	1,028	1,810	1,117	2,128
Net Cash Growth	75.65%	-43.23%	62.12%	-47.53%	-46.99%
Net Cash Per Share	5.40	3.20	5.78	3.75	7.26
Filing Date Shares Outstanding	343.75	324.35	319.36	305.46	294.41
Total Common Shares Outstanding	343.75	324.35	319.36	305.46	294.41
Working Capital	2,684	1,222	2,179	2,544	2,418
Book Value Per Share	15.43	12.56	15.56	18.51	20.01
Tangible Book Value	3,213	1,818	2,445	3,276	3,421
Tangible Book Value Per Share	9.35	5.61	7.66	10.72	11.62
Buildings	-	461.02	437.87	378.28	-
Machinery	-	179.16	167.32	84.66	5.72
Construction In Progress	-	-	9.79	45.75	102.91
Leasehold Improvements	-	48.17	46.9	44.77	15.91

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.